The area under the receiver operating characteristic curve (AUC) is a popular threshold-free metric to retrospectively measure the discriminatory performance of medical tests. In risk prediction or medical screening, main interests often focus on accurately predicting the future risk of an event of interest or prospectively stratifying individuals into risk categories. Thus, AUC might not be optimal in assessing the predictive performance for such purposes. Alternative accuracy measures have been proposed, such as the positive predictive value (PPV). Yuan et al. (2015) proposed a threshold-free metric, the average positive predictive value (AP), which is the area under the PPV versus true positive fraction (TPF) curve, when the outcome is b...
The positive and negative predictive value are standard measures used to quantify the predictive acc...
We propose a graphical measure, the generalized negative predictive function, to quantify the predic...
There are two popular statistical approaches to biomarker evaluation. One models the risk of disease...
Prediction performance of a risk scoring system needs to be carefully assessed before its adoption i...
International audienceFinding out biomarkers and building risk scores to predict the occurrence of s...
† These authors contributed equally to this paper. When evaluating medical tests or biomarkers for d...
Summary. Competing risks arise naturally in time-to-event studies. In this article, we propose time-...
In a prospective cohort study, information on clinical parameters, tests and molecular markers is of...
This is a pre-copyedited, author-produced PDF of an article accepted for publication in Biostatistic...
When constructing models to summarize clinical data to be used for simulations, it is good prac-tice...
A marker's capacity to predict risk of a disease depends on disease prevalence in the target po...
Although the area under the receiver operating characteristic (AUC) is the most popular measure of t...
As a cost effective diagnostic tool, numerous candidate biomarkers have been emerged for different d...
The ROC curve and the corresponding AUC are popular tools for the evaluation of diagnostic tests. Th...
In time to event data analysis, it is often of interest to predict quantities such as t-year surviva...
The positive and negative predictive value are standard measures used to quantify the predictive acc...
We propose a graphical measure, the generalized negative predictive function, to quantify the predic...
There are two popular statistical approaches to biomarker evaluation. One models the risk of disease...
Prediction performance of a risk scoring system needs to be carefully assessed before its adoption i...
International audienceFinding out biomarkers and building risk scores to predict the occurrence of s...
† These authors contributed equally to this paper. When evaluating medical tests or biomarkers for d...
Summary. Competing risks arise naturally in time-to-event studies. In this article, we propose time-...
In a prospective cohort study, information on clinical parameters, tests and molecular markers is of...
This is a pre-copyedited, author-produced PDF of an article accepted for publication in Biostatistic...
When constructing models to summarize clinical data to be used for simulations, it is good prac-tice...
A marker's capacity to predict risk of a disease depends on disease prevalence in the target po...
Although the area under the receiver operating characteristic (AUC) is the most popular measure of t...
As a cost effective diagnostic tool, numerous candidate biomarkers have been emerged for different d...
The ROC curve and the corresponding AUC are popular tools for the evaluation of diagnostic tests. Th...
In time to event data analysis, it is often of interest to predict quantities such as t-year surviva...
The positive and negative predictive value are standard measures used to quantify the predictive acc...
We propose a graphical measure, the generalized negative predictive function, to quantify the predic...
There are two popular statistical approaches to biomarker evaluation. One models the risk of disease...